David A. Montecalvo
2019
Compensation breakdown
Change in Pension Value and Nonqualified Deferred Compensation Earnings | $10,591 |
---|---|
Non-Equity Incentive Plan | $341,998 |
Option Awards | $200,002 |
Salary | $421,923 |
Stock Awards | $211,244 |
Other | $37,728 |
Total | $1,223,485 |
Montecalvo received $421.9K in salary, accounting for 34% of the total pay in 2019.
Montecalvo also received $10.6K of change in pension value and nonqualified deferred compensation earnings, $342K in non-equity incentive plan, $200K in option awards, $211.2K in stock awards and $37.7K in other compensation.
Rankings
In 2019, David A. Montecalvo's compensation ranked 8,333rd out of 13,971 executives tracked by ExecPay. In other words, Montecalvo earned more than 40.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,333 | 40th |
Manufacturing | 3,292 | 42nd |
Rubber And Miscellaneous Plastics Products | 58 | 33rd |
Fabricated Rubber Products, Not Elsewhere | 11 | 21st |
Montecalvo's colleagues
We found five more compensation records of executives who worked with David A. Montecalvo at West Pharmaceutical Services in 2019.
2019
Eric Green
West Pharmaceutical Services
Chief Executive Officer
2019
Bernard Birkett
West Pharmaceutical Services
Chief Financial Officer
2019
Karen Flynn
West Pharmaceutical Services
Former SVP & Chief Commercial Officer
2019
George Miller
West Pharmaceutical Services
General Counsel
2019
Silji Abraham
West Pharmaceutical Services
SVP & Chief Digital Transf Officer
News
April 14, 2022
March 24, 2021
March 25, 2020
March 22, 2019